title: Early amelioration of insulin resistance and reduction of interleukin-6 in Werner syndrome using pioglitazone.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Honjo
authors.forename: Koutaro
authors.initials: K
authors.lastname: Yokote
authors.forename: Takeshi
authors.initials: T
authors.lastname: Fujishiro
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Maezawa
authors.forename: Seiya
authors.initials: S
authors.lastname: Sato
authors.forename: Masaya
authors.initials: M
authors.lastname: Koshizaka
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Saito
mesh_terms: D015415:Biomarkers / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D000077205:Pioglitazone; D011972:Receptor, Insulin / Q000187:drug effects; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014898:Werner Syndrome / Q000097:blood / Q000188:drug therapy*
chemical_list: D015415:Biomarkers; D007004:Hypoglycemic Agents; D015850:Interleukin-6; D045162:Thiazolidinediones; D011972:Receptor, Insulin; D000077205:Pioglitazone